FAM83H‐AS1 is associated with clinical progression and modulates cell proliferation, migration, and invasion in bladder cancer
Author:
Affiliation:
1. Department of Urology Beijing Chaoyang Hospital, Capital Medical University Beijing China
2. Department of Urology Hebei Yanda Hospital Hebei China
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27758
Reference22 articles.
1. Global cancer statistics, 2012
2. Cancer statistics in China, 2015
3. Alternative therapies in patients with non-muscle invasive bladder cancer
4. Different stages in drug development for muscle-invasive bladder cancer
5. The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis;Frontiers in Genetics;2022-02-22
2. Prognostic Value of Long Non-coding RNAs in Urological Malignancies: A Systematic Review, and Meta-Analysis;The Open Biomarkers Journal;2021-12-20
3. FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells;BMC Cancer;2021-12
4. Biological functions and clinical significance of long noncoding RNAs in bladder cancer;Cell Death Discovery;2021-10-05
5. Gene Expression Profiling and Biofunction Analysis of HepG2 Cells Targeted by Crocetin;Mediators of Inflammation;2021-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3